Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wallentin

Showing results (31-40 of 186) with videos related to

Pageof 19
Sort By:
The Journal of Urology|November 1, 1989
Re: The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinomaE Varenhorst, L Wallentin
Thrombosis and Haemostasis|June 30, 1986
Ticlopidine and platelet function--rejoinderU Berglund, L Wallentin
Thrombosis and Haemostasis|June 3, 1987
Platelet reactivity in unstable coronary artery diseaseE Swahn, L Wallentin
European Journal of Clinical Investigation|December 1, 1981
High density lipoprotein and other lipoproteins in normolipidaemic and hypertriglyceridaemic (type IV) men with coronary artery diseaseB Moberg, L Wallentin
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1981
Lipoproteins and cholesterol esterification rate in men and women with hypercholesterolaemia of type IIaB Moberg, L Wallentin
European Heart Journal|March 1, 1991
Persistent inhibition of platelet function during long-term treatment with 75 mg acetylsalicylic acid daily in men with unstable coronary artery diseaseU Berglund, L Wallentin
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1985
Effects of ticlopidine on platelet function and on coronary insufficiency in patients with angina pectorisU Berglund, L Wallentin
Atherosclerosis|February 1, 1986
HDL2 and HDL3 lipid levels in coronary artery diseaseL Wallentin, B Sundin
Atherosclerosis|March 1, 1986
Influence on lipoprotein metabolism of the platelet inhibitory drug ticlopidineU Berglund, L Wallentin
JAMA|March 10, 2001
Early statin treatment following acute myocardial infarction and 1-year survivalU Stenestrand, L Wallentin,
Pageof 19

Showing results (31-40 of 186) with videos related to

Sort By:
Pageof 19
The Journal of Urology|November 1, 1989
Re: The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinomaE Varenhorst, L Wallentin
Thrombosis and Haemostasis|June 30, 1986
Ticlopidine and platelet function--rejoinderU Berglund, L Wallentin
Thrombosis and Haemostasis|June 3, 1987
Platelet reactivity in unstable coronary artery diseaseE Swahn, L Wallentin
European Journal of Clinical Investigation|December 1, 1981
High density lipoprotein and other lipoproteins in normolipidaemic and hypertriglyceridaemic (type IV) men with coronary artery diseaseB Moberg, L Wallentin
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1981
Lipoproteins and cholesterol esterification rate in men and women with hypercholesterolaemia of type IIaB Moberg, L Wallentin
European Heart Journal|March 1, 1991
Persistent inhibition of platelet function during long-term treatment with 75 mg acetylsalicylic acid daily in men with unstable coronary artery diseaseU Berglund, L Wallentin
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1985
Effects of ticlopidine on platelet function and on coronary insufficiency in patients with angina pectorisU Berglund, L Wallentin
Atherosclerosis|February 1, 1986
HDL2 and HDL3 lipid levels in coronary artery diseaseL Wallentin, B Sundin
Atherosclerosis|March 1, 1986
Influence on lipoprotein metabolism of the platelet inhibitory drug ticlopidineU Berglund, L Wallentin
JAMA|March 10, 2001
Early statin treatment following acute myocardial infarction and 1-year survivalU Stenestrand, L Wallentin,
Pageof 19